PDF (5628K)
摘要
目的: 基于靶点筛选与通路分析初步预测芍药苷改善干燥综合征 (Sjögren's syndrome,SS)相关泪腺炎症损伤的潜在作用方向,并通过分子对接与动物实验进行初步验证。方法: 基于靶点筛选与通路分析初步预测芍药苷改善 SS 相关泪腺炎症损伤的潜在作用方向,并通过分子对接与动物实验进行验证。建立 NOD/ShiLtJ 小鼠 SS 相关干眼模型,给予不同剂量芍药苷及羟氯喹干预,通过泪液分泌、组织学及分子生物学方法评价泪腺炎症损伤。结果: 通路分析提示炎症小体相关信号可能参与芍药苷的作用;分子对接显示芍药苷与 NLRP3 和 Caspase-1 具有较好结合亲和力。动物实验结果显示,芍药苷干预后 SS 小鼠泪液分泌功能、泪腺炎症浸润及组织损伤有所改善,并伴随 IL-6、IL-18、IL-1β、TNF-α 及 NLRP3、Caspase-1 表达水平降低。结论: 本研究初步提示,芍药苷可能改善 SS 相关泪腺炎症损伤,其作用可能与炎症反应调节及 NLRP3/Caspase-1 相关过程有关。
Abstract
AIM: To preliminarily predict the potential action direction of paeoniflorin in alleviating lacrimal gland inflammatory injury associated with Sjögren's syndrome (SS) based on target screening and pathway analysis, and to provide preliminary validation through molecular docking and animal experiments. METHODS: Candidate targets of paeoniflorin and SS were screened from public databases and subjected to pathway enrichment analysis to identify inflammation-related signaling directions. Molecular docking was then performed to evaluate the binding characteristics between paeoniflorin and key inflammatory proteins. An SS-related dry eye model was established in male NOD/ShiLtJ mice, which were treated with different doses of paeoniflorin or hydroxychloroquine for four weeks. Tear secretion was measured to assess lacrimal gland function. Histopathological changes were evaluated by hematoxylin–eosin (HE) staining, and the expression levels of inflammatory mediators and signaling proteins in lacrimal glands were determined using RT-qPCR and western blot. RESULTS: Pathway analysis indicated that inflammasome-related signaling, particularly the NOD-like receptor pathway, may be involved in the action of paeoniflorin. Molecular docking showed that paeoniflorin exhibited favorable binding affinity to NLRP3 and Caspase-1. Animal experiments indicated that paeoniflorin treatment improved tear secretion, alleviated lacrimal gland inflammatory infiltration and tissue injury in SS mice, and was accompanied by reduced expression levels of IL-6, IL-18, IL-1β, TNF-α, NLRP3, and Caspase-1. CONCLUSION: This study provides preliminary evidence that paeoniflorin may ameliorate SS-related lacrimal gland inflammatory injury, possibly through modulation of inflammatory responses and NLRP3/Caspase-1–related processes.
关键词
Key words
[Author(id=1330571806550528745, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330558534938006007, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=andyandyhan@163.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330571806609249004, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330558534938006007, authorId=1330571806550528745, language=EN, stringName=Xuemei HAN, firstName=Xuemei, middleName=null, lastName=HAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Ophthalmology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou 310006, Zhejiang, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330571806651192046, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330558534938006007, authorId=1330571806550528745, language=CN, stringName=韩雪梅, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=浙江中医药大学附属第一医院(浙江省中医院) 眼科,杭州 310006,浙江, bio={"content":"韩雪梅,女,硕士研究生,主治医师,研究方向:中西医结合治疗眼表、泪道疾病。 E-mail:andyandyhan@163.com
"}, bioImg=null, bioContent=韩雪梅,女,硕士研究生,主治医师,研究方向:中西医结合治疗眼表、泪道疾病。 E-mail:andyandyhan@163.com
, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330571806475031267, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330558534938006007, xref=null, ext=[AuthorCompanyExt(id=1330571806491808484, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330558534938006007, companyId=1330571806475031267, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Ophthalmology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou 310006, Zhejiang, China), AuthorCompanyExt(id=1330571806504391397, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330558534938006007, companyId=1330571806475031267, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=浙江中医药大学附属第一医院(浙江省中医院) 眼科,杭州 310006,浙江)])]), Author(id=1330571806697329394, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330558534938006007, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330571806756049653, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330558534938006007, authorId=1330571806697329394, language=EN, stringName=Hua ZHOU, firstName=Hua, middleName=null, lastName=ZHOU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Ophthalmology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou 310006, Zhejiang, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330571806802186998, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330558534938006007, authorId=1330571806697329394, language=CN, stringName=周骅, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=浙江中医药大学附属第一医院(浙江省中医院) 眼科,杭州 310006,浙江, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330571806475031267, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330558534938006007, xref=null, ext=[AuthorCompanyExt(id=1330571806491808484, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330558534938006007, companyId=1330571806475031267, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Ophthalmology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou 310006, Zhejiang, China), AuthorCompanyExt(id=1330571806504391397, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330558534938006007, companyId=1330571806475031267, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=浙江中医药大学附属第一医院(浙江省中医院) 眼科,杭州 310006,浙江)])]), Author(id=1330571806848324345, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330558534938006007, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=20013073@zcmu.edu.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330571806902850299, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330558534938006007, authorId=1330571806848324345, language=EN, stringName=Chunzi LIU, firstName=Chunzi, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Ophthalmology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou 310006, Zhejiang, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330571806948987645, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330558534938006007, authorId=1330571806848324345, language=CN, stringName=刘春姿, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=浙江中医药大学附属第一医院(浙江省中医院) 眼科,杭州 310006,浙江, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330571806475031267, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330558534938006007, xref=null, ext=[AuthorCompanyExt(id=1330571806491808484, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330558534938006007, companyId=1330571806475031267, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Ophthalmology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou 310006, Zhejiang, China), AuthorCompanyExt(id=1330571806504391397, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330558534938006007, companyId=1330571806475031267, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=浙江中医药大学附属第一医院(浙江省中医院) 眼科,杭州 310006,浙江)])])]
韩雪梅,周骅,刘春姿.
芍药苷改善干燥综合征相关泪腺炎症损伤的作用机制研究[J].
中国临床药理学与治疗学, 2026, 31(9): 1214-1220 DOI:10.12092/j.issn.1009-2501.2026.09.007
| [1] |
Balint G, Watson Buchanan W, Kean CA, et al. Sjogren's syndrome[J].Inflammopharmacol, 2024, 32(1): 37-43.
|
| [2] |
Bjordal O, Norheim KB, Rodahl E, et al. Primary Sjogren's syndrome and the eye[J].Surv Ophthalmol, 2020, 65(2): 119-132.
|
| [3] |
Fana V, Terslev L. Lacrimal and salivary gland ultrasound-how and when to use in patients with primary Sjogren's syndrome[J].Best Pract Res Clin Rheumatol, 2023, 37(1): 101837.
|
| [4] |
Beydon M, McCoy S, Nguyen Y, et al. Epidemiology of Sjogren syndrome[J].Nat Rev Rheumatol, 2024, 20(3): 158-169.
|
| [5] |
Fox RI, Fox CM, Gottenberg JE, et al. Treatment of Sjogren's syndrome: current therapy and future directions[J].Rheumatology (Oxford), 2021, 60(5): 2066-2074.
|
| [6] |
Sun M, Wei Y, Zhang C, et al. Integrated DNA methylation and transcriptomics analyses of lacrimal glands identify the potential genes implicated in the development of Sjogren's syndrome-related dry eye[J].J Inflamm Res, 2023, 16: 5697-5714.
|
| [7] |
Caban M, Omulecki W, Latecka-Krajewska B. Dry eye in Sjogren's syndrome-characteristics and therapy[J].Eur J Ophthalmol, 2022, 32(6): 3174-3184.
|
| [8] |
Singh S, Chaudhary S, Das AV, et al. Presentation, aetiology and outcomes of corneal ulceration in Sjogren's syndrome[J].Eye (Lond), 2023, 37(15): 3217-3220.
|
| [9] |
Hayashi T. Dysfunction of lacrimal and salivary glands in Sjogren's syndrome: nonimmunologic injury in pre-inflammatory phase and mouse model[J].J Biomed Biotechnol, 2011, 2011: 407031.
|
| [10] |
Zhou YX, Gong XH, Zhang H, et al. A review on the pharmacokinetics of paeoniflorin and its anti-inflammatory and immunomodulatory effects[J].Biomed Pharmacother, 2020, 130: 110505.
|
| [11] |
范文强, 路依林, 张超, 等. 芍药苷通过调控 ALOX5 表达调节铁死亡缓解类风湿性关节炎[J].中草药, 2025, 56(23): 8645-8653.
|
| [12] |
Ma J, Meng Q, Zhan J, et al. Paeoniflorin suppresses rheumatoid arthritis development via modulating the Circ-FAM120A/miR-671-5p/MDM4 axis[J].Inflammation, 2021, 44(6): 2309-2322.
|
| [13] |
Wang S, Zhao X, Qiao Z, et al. Paeoniflorin attenuates depressive behaviors in systemic lupus erythematosus mice[J].Biomed Pharmacother, 2018, 103: 248-252.
|
| [14] |
He J, Wang Y, Xu L, et al. Ruscogenin ameliorated Sjogren's syndrome by inhibiting NLRP3 inflammasome activation[J].Evid Based Complement Alternat Med, 2022, 2022: 6425121.
|
| [15] |
Scuron MD, Fay B, Oliver J, et al. Spontaneous model of Sjogren's syndrome in NOD mice[J].Curr Protoc Pharmacol, 2019, 86(1): e65.
|
| [16] |
Nakamura S, Shibuya M, Saito Y, et al. Protective effect of D-beta-hydroxybutyrate on corneal epithelia in dry eye conditions through suppression of apoptosis[J].Invest Ophthalmol Vis Sci, 2003, 44(11): 4682-4688.
|
| [17] |
亚洲干眼协会中国分会, 海峡两岸医药卫生交流协会眼科学专业委员会眼表与泪液病学组, 中国医师协会眼科医师分会眼表与干眼学组. 中国干眼专家共识: 免疫性疾病相关性干眼 (2021 年)[J].中华眼科杂志, 2021, 57(12): 898-907.
|
| [18] |
Rattner A, Heng JS, Winer BL, et al. Normal and Sjogren's syndrome models of the murine lacrimal gland studied at single-cell resolution[J].Proc Natl Acad Sci U S A, 2023, 120(42): e2311983120.
|
| [19] |
Toth-Molnar E, Ding C.New insight into lacrimal gland function: role of the duct epithelium in tear secretion[J].Ocul Surf, 2020, 18(4): 595-603.
|
| [20] |
Chen Y, Ye X, Escames G, et al. The NLRP3 inflammasome: contributions to inflammation-related diseases[J].Cell Mol Biol Lett, 2023, 28(1): 51.
|
| [21] |
Vande Walle L, Lamkanfi M. Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets[J].Nat Rev Drug Discov, 2024, 23(1): 43-66.
|
基金资助
浙江省中医药科技计划项目(2024ZL451)
浙江中医药大学科研项目(2025JKZKTS57)